1. Use of systemic therapy in the treatment of choroidal metastases from breast cancer.
- Author
-
Alzouebi M, Ramakrishnan S, Rennie I, and Salvi S
- Subjects
- Aged, Antibodies, Monoclonal, Humanized administration & dosage, Antineoplastic Agents, Phytogenic administration & dosage, Breast Neoplasms chemistry, Female, Humans, Paclitaxel administration & dosage, Receptor, ErbB-2 analysis, Receptors, Estrogen analysis, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms pathology, Choroid Neoplasms drug therapy, Choroid Neoplasms secondary
- Abstract
This is a case report on the use of systemic therapy to successfully regress choroidal metastases due to breast cancer. The choroid is the commonest site for intraocular metastatic disease. Breast and lung cancer are frequently the primary malignancies. Traditionally, choroidal metastases are treated with local therapy to the eye including using either external beam radiotherapy, brachytherapy or, recently, with photodynamic therapy. We report on the impressive results obtained with the use of palliative paclitaxel chemotherapy and trastuzumab after only 8 weeks. Funduscopic images and ultrasound findings support this., (2014 BMJ Publishing Group Ltd.)
- Published
- 2014
- Full Text
- View/download PDF